Assenagon Asset Management S.A. lessened its holdings in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 63.2% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 114,618 shares of the…